S Winer, MD, MPH

Professor of Clinical Obstetrics & Gynecology, Co-Director, REI Clinic

Is this your profile? Click to edit

Publications

Comparison of estrogenic components used for hormonal contraception Contraception. 2024 Feb; 130:110310. . View in PubMed
Family Planning, Fertility, and Medical School: A Survey of Students’ Plans and Perceptions of Institutional Support Perm J. 2023 09 15; 27(3):37-48. . View in PubMed
Does timing matter when initiating elagolix in a natural menstrual cycle? F S Rep. 2021 Sep; 2(3):308-313.. View in PubMed
Bioidentical hormones Climacteric. 2021 02; 24(1):38-45. . View in PubMed
Successful Vaginal Delivery after External Cephalic Version in a Woman with a Large Partial Uterine Septum Case Rep Obstet Gynecol. 2021; 2021:9912271. . View in PubMed
Effect of hormone therapy on breast epithelial cell proliferation Menopause. 2013 May; 20(5):483-5. . View in PubMed
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects Endocr Rev. 2013 Apr; 34(2):171-208. . View in PubMed
Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness Expert Rev Pharmacoecon Outcomes Res. 2009 Apr; 9(2):157-70. . View in PubMed
The pharmacologic management of premenstrual dysphoric disorder Expert Opin Pharmacother. 2008 Feb; 9(3):429-45. . View in PubMed
Drospirenone/ethinyl estradiol Drugs Today (Barc). 2008 Feb; 44(2):133-45. . View in PubMed
Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder Womens Health (Lond). 2007 Jul; 3(4):395-408. . View in PubMed
Drospirenone: a novel progestin Expert Opin Pharmacother. 2007 May; 8(7):989-99. . View in PubMed
Premenstrual disorders: prevalence, etiology and impact J Reprod Med. 2006 Apr; 51(4 Suppl):339-47. . View in PubMed

S Winer, MD, MPH

Publications

Similar People